Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced adrenocortical carcinoma from the JAVELIN solid tumor phase Ib trial: Safety and clinical activity - Le Tourneau, C; Hoimes, C J; Zarwan, C (J Clin Oncol, 2016)
et al.